Invention Grant
- Patent Title: Resorcinol derivatives
-
Application No.: US15800930Application Date: 2017-11-01
-
Publication No.: US10202322B2Publication Date: 2019-02-12
- Inventor: Sean D. McAllister , Pierre-Yves Desprez , Anuradha Mahadevan
- Applicant: Sutter West Bay Hospitals
- Applicant Address: US CA San Francisco
- Assignee: Sutter Bay Hospitals
- Current Assignee: Sutter Bay Hospitals
- Current Assignee Address: US CA San Francisco
- Agency: Gavrilovich, Dodd & Lindsey LLP
- Main IPC: C07F9/12
- IPC: C07F9/12 ; A61K31/05 ; A61K45/06 ; C07C39/17 ; C07C39/23 ; C07C39/42 ; C07C43/21 ; C07C43/23 ; C07C69/16 ; C07C69/40 ; A61K31/337 ; A61K31/352 ; C07C271/44 ; C07C309/17 ; C07C69/017 ; C07D213/80 ; C07D295/30 ; C07D333/10 ; A61K31/4188 ; C07D295/096
Abstract:
The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
Public/Granted literature
- US20180170846A1 RESORCINOL DERIVATIVES Public/Granted day:2018-06-21
Information query
